BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 480 | Download: 332
Publication Name World Journal of Stem Cells
Manuscript ID 6791
Country/Territory United States
Received
2013-10-29 10:09
Peer-Review Started
2013-10-30 10:54
To Make the First Decision
2013-12-25 18:00
Return for Revision
2013-12-30 15:54
Revised
2014-01-14 12:03
Second Decision
2014-03-04 09:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-04 10:31
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-04-19 15:55
Publish the Manuscript Online
2014-04-28 14:14
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research and Experimental
Manuscript Type Review
Article Title Progress of mesenchymal stem cell therapy for neural and retinal diseases
Manuscript Source Invited Manuscript
All Author List Tsz Kin Ng, Veronica R Fortino, Daniel Pelaez and Herman S Cheung
Funding Agency and Grant Number
Funding Agency Grant Number
Veterans Affairs (VA) Merit Review Grant
Senior VA Research Career Scientist Award, Miami
Corresponding author Herman S Cheung, PhD, Professor, Geriatric Research, Education and Clinical Center, Miami Veterans Affairs Medical Center, 1201 NW 16th Street, Miami, FL 33125, United States. hcheung@med.maimi.edu
Keywords Mesenchymal stem cells; Stem cell therapy; Central nervous system; Retina; Clinical trial
Core Tip Central nervous system (CNS) disorders are the most challenging and difficult for functional repair. Neurons are still diminishing in many patients despite surgical and medical interventions. Stem cell therapy has been proposed as a viable option. Mesenchymal stem cell (MSC) is a widely-studied human adult stem cell population. MSCs can be conveniently obtained from different accessible tissues. MSCs have high proliferative and differentiation abilities, providing an inexhaustible source of neurons and glia. MSCs also show neuroprotective effects and possess extraordinary immunomodulatory properties. These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders.
Publish Date 2014-04-28 14:14
Citation Ng TK, Fortino VR, Pelaez D, Cheung HS. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells 2014; 6(2): 111-119
Url http://www.wjgnet.com/1948-0210/full/v6/i2/111.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i2.111
Full Article (PDF) WJSC-6-111.pdf
Full Article (Word) WJSC-6-111.doc
Manuscript File 6791-Review.docx
Answering Reviewers 6791-Answering reviewers.pdf
Copyright License Agreement 6791-Copyright assignment.pdf
Peer-review Report 6791-Peer review(s).pdf
Scientific Editor Work List 6791-Scientific editor work list.doc